Isoprostane as oxidative stress biomarker in the VARIAFIT study: Analytical and methodological considerations-Reference-Cited by-同舟云学术

Isoprostane as oxidative stress biomarker in the VARIAFIT study: Analytical and methodological considerations

Published:2014-09 Issue:4 Volume:40 Page:316-317
ISSN:1262-3636
Container-title:Diabetes & Metabolism
language:en
Short-container-title:Diabetes & Metabolism

Author:

Monneret D.^ORCID

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference10 articles.

1. Impact of flexible insulin therapy on blood glucose variability, oxidative stress and inflammation in type 1 diabetic patients: the VARIAFIT study;Benhamou;Diabetes Metab,2014

2. Association of urinary 15-F2t-isoprostane level with oxygen desaturation and carotid intima-media thickness in nonobese sleep apnea patients;Monneret;Free Radic Biol Med,2010

3. Estimation of the limit of detection for urinary 8-isoprostanes purified by immnoextraction affinity and measured by liquid chromatography coupled to tandem mass spectrometry. Figshare;Monneret,2014

4. Quantification of 15-F2t-isoprostane in human plasma and urine: Results from enzyme-linked immunoassay and liquid chromatography/tandem mass spectrometry cannot be compared;Klawitter;Rapid Commun Mass Spectrom,2011

5. The reference change value: a proposal to interpret laboratory reports in serial testing based on biological variation;Ricos;Scand J Clin Lab Invest,2004

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paradoxical decrease in isoprostane and increase in superoxide dismutase following CPAP withdrawal in OSA;European Respiratory Journal;2016-02-29

2. Isoprostane as a promising prognostic biomarker in pulmonary arterial hypertension: preanalytical and analytical viewpoints;International Journal of Cardiology;2014-12